| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/20/2006 | EP1701700A1 Compositions comprising memantine and polyanionic polymers for administration to the eye |
| 09/20/2006 | EP1527341A4 Interfacial biomaterials |
| 09/20/2006 | EP1515682B1 Biliquid foam entrapment |
| 09/20/2006 | EP1494648B1 Powder formulations suitable for inhalation |
| 09/20/2006 | EP1492513B1 Hfa-suspension formulations containing an anticholinergic |
| 09/20/2006 | EP1272530B1 Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 09/20/2006 | EP1158970B1 Combinations of formoterol and a tiotropium salt |
| 09/20/2006 | EP1037611A4 Biodegradable mixed polymeric micelles for gene delivery |
| 09/20/2006 | CN1835970A Peptides enhancing CEH activity or ACAT inhibitory activity, pharmaceutical compositions comrising these peptides and their use in the treatment of atherosclerosis |
| 09/20/2006 | CN1835770A Pharmaceutical compositions |
| 09/20/2006 | CN1835769A KIM-1 antagonists and use to modulate immune system |
| 09/20/2006 | CN1835758A Glycyrrhizin high-concentration preparation |
| 09/20/2006 | CN1835752A Multivitamin syrup for children or young adults |
| 09/20/2006 | CN1835742A Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
| 09/20/2006 | CN1835735A Drug delivery system for administering fine particle under tenon's capsule |
| 09/20/2006 | CN1835726A Compositions for the preparation of carbon dioxide gel for external use and carbon dioxide gels for external use |
| 09/20/2006 | CN1835723A Deployable multifunctional hemostatic agent |
| 09/20/2006 | CN1835722A Transdermal hormone delivery system: compositions and methods |
| 09/20/2006 | CN1834001A Nano medicine self-guide, self-assembling quantumized electrical conductive joint and prepn. thereof |
| 09/20/2006 | CN1833726A Chitosan pellet having bioactivity medicine and prepn. method |
| 09/20/2006 | CN1833725A Chitosan pellet/microsac and prepn. thereof |
| 09/20/2006 | CN1833643A Entikawei solid dispersion compsns. and prepn. thereof |
| 09/20/2006 | CN1833633A Liposome able to transmit blood and brain screen, medicinal compsns. using hiposome as carrier and its prepn. method |
| 09/20/2006 | CN1833542A Improved method for drying neotame with co-agents |
| 09/20/2006 | CN1276016C Hydroxy propyl-beta-cyclodextrin inclusion compound of anisolene and its preparation and preparation method |
| 09/20/2006 | CN1275994C Liquid dispersion polymer compositions, their preparation and their use |
| 09/20/2006 | CN1275968C Non crystalline tricyclic triazolobenzazepine derivative |
| 09/20/2006 | CN1275651C Medical coating powder containing nano material |
| 09/20/2006 | CN1275650C Coupled compound of 5-methyl-morpholine-3-amino-2-oxazolidinone and preparation method thereof |
| 09/20/2006 | CN1275648C Vaccin composition, preparation method and use thereof |
| 09/20/2006 | CN1275606C Medical usage of simonder wood oil |
| 09/20/2006 | CN1275601C Composition and method of tissue superoxygenation |
| 09/20/2006 | CN1275592C Oily thixotropic formulations |
| 09/19/2006 | US7109309 Peptide fructose and protein conjugate with the same |
| 09/19/2006 | US7109303 Modified cytokines for use in cancer therapy |
| 09/19/2006 | US7109301 Tenascin-C isoform as marker for neoplasias |
| 09/19/2006 | US7109255 Bioresorbable hydrogel compositions for implantable prostheses |
| 09/19/2006 | US7109247 Stabilized particle dispersions containing nanoparticles |
| 09/19/2006 | US7109246 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7109185 Pharmaceutical formulations comprising indolinone derivatives |
| 09/19/2006 | US7109173 Ability to transport ribonucleic acids into cells, can be employed in gene silencing by RNAi (ribonucleic acid interference) and antisense therapy; for delivering substances into the cytosol and nucleus of living cells |
| 09/19/2006 | US7109171 Reducing FSH levels by administering a GnRH antagonist to reduce both plasma FSH and LH levels; treating prostatic intraepithelial neoplasia, pedophilia, infertility, vaginal bleeding; in vitro fertilization and male contraception |
| 09/19/2006 | US7109167 Tetrapeptide |
| 09/19/2006 | US7109166 A piperazine-somatostatin analog in sustained release ionic conjugate with lactic acid-glycolic acid-tartaric acid copolymer; for therapy of gastrointestinal disorders, such as Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis |
| 09/19/2006 | US7109163 For use in hemostatic devices that are suitable for applying a flowable hemostatic formulation to a site requiring hemostasis |
| 09/19/2006 | US7108886 Addition of a liquid coating syrup to a moving mass of cores for comestibles in a rotating pan and obtaining a plurality of sugar-free hard-coated comestibles having a hard coating on an edible, chewable and/or pharmaceutical core wherein layer of hard coating is directly in contact with core |
| 09/19/2006 | US7108873 Gelatinous food elastomer compositions and articles |
| 09/19/2006 | US7108866 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/19/2006 | US7108865 Controlled-release dosage forms of azithromycin |
| 09/19/2006 | US7108864 Non-sustained release combination of a rapidly precipitating drug, a binder, a superdisintegrant, and optionally a lubricant that are mixed and compressed into a tablet without heating, solvent or grinding. |
| 09/19/2006 | US7108863 Liposome composition for improved intracellular delivery of a therapeutic agent |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | US7108844 Use of stabilized oligonucleotides for preparing a medicament with antitumor activity |
| 09/19/2006 | US7108125 Extendable belt conveyor |
| 09/19/2006 | CA2388830C Oral solution containing galanthamine and a sweetening agent |
| 09/19/2006 | CA2248186C Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 09/19/2006 | CA2238352C Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/15/2006 | CA2500907A1 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/14/2006 | WO2006096535A1 Method for analyzing activated polyethylene glycol compounds |
| 09/14/2006 | WO2006096491A2 Anti-ctla-4 antibody compositions |
| 09/14/2006 | WO2006096360A1 Topical gels compositions |
| 09/14/2006 | WO2006096207A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 09/14/2006 | WO2006096084A1 Methods for intradermal, transdermal or transmucosal delivery of biologically active substances |
| 09/14/2006 | WO2006095870A1 Photosensitizer, protein-cleaving agent, method of cleaving protein, sugar molecule-cleaving agent, method of cleaving sugar molecule, and photodynamic therapeutic agent |
| 09/14/2006 | WO2006095858A1 Composition for treating bacterial disease in the oral cavity, liquid agent for washing treatment, liquid agent for hemostasis treatment and method of treating bacterial disease in the oral cavity |
| 09/14/2006 | WO2006095844A1 Pharmaceutical preparation |
| 09/14/2006 | WO2006095837A1 Lipid membrane structure capable of delivering target substance into mitochondrion |
| 09/14/2006 | WO2006095820A1 Adhesive and adhesive patch |
| 09/14/2006 | WO2006095819A1 Sugar-coated pill |
| 09/14/2006 | WO2006095798A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome |
| 09/14/2006 | WO2006095788A1 Particle and preparation containing the particle |
| 09/14/2006 | WO2006095775A1 Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue |
| 09/14/2006 | WO2006095668A1 Microparticle and pharmaceutical composition |
| 09/14/2006 | WO2006095636A1 Novel compound selectively activated at target site and utilization of the same |
| 09/14/2006 | WO2006095542A1 Pharmaceutical composition comprising amine compound |
| 09/14/2006 | WO2006095363A2 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
| 09/14/2006 | WO2006095345A2 Targeted drug-carrying bacteriophages |
| 09/14/2006 | WO2006095029A2 Di-polymer protein conjugates and processes for their preparation |
| 09/14/2006 | WO2006094829A1 Microemulsions of cannabinoid receptor binding compounds |
| 09/14/2006 | WO2006094828A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 09/14/2006 | WO2006094826A2 Method for coupling enzymatically activated glycoconjugates to a hydroxyalkyl starch |
| 09/14/2006 | WO2006094810A2 Production of bioactive glycoproteins from inactive starting material by conjugation with hydroxyalkylstarch |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094681A1 Non-fibrous transdermal therapeutic system and method for its production |
| 09/14/2006 | WO2006094664A1 Endoparasiticide |
| 09/14/2006 | WO2006094530A1 Di-polymer protein conjugates and processes for their preparation |
| 09/14/2006 | WO2006078593A3 Direct compression formulation and process |
| 09/14/2006 | WO2006061101A3 Drug delivery peptides for crossing blood-brain barrier |
| 09/14/2006 | WO2006005910A3 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
| 09/14/2006 | WO2005121793A3 Detection of methamphetamine group drugs |
| 09/14/2006 | WO2005120462A3 Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures |
| 09/14/2006 | WO2005105152A3 Lipids, lipid complexes and use thereof |
| 09/14/2006 | WO2005089807A3 Antibody calicheamicin conjugates for passive targeting |
| 09/14/2006 | WO2004064731A3 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues |
| 09/14/2006 | US20060205820 Formulations of anthraquinone derivatives |
| 09/14/2006 | US20060205746 For the treatment of hyperproliferative disorders like actinic keratosis, anogenital warts, seborrhoic keratosis, skin cancer; topical application with good physico-chemical stability, good penetration |
| 09/14/2006 | US20060205725 Method for treating ocular hypertension and glaucoma |
| 09/14/2006 | US20060205703 Stabilized steroid composition and method for its preparation |